Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Q32 Bio Inc (QTTB)

70 + Investors. Track Smart Money conviction in QTTB. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +18
Streak
2Q ▲
Buyers last Q
66%

Smart Money Signals — QTTB

Based on 70 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added QTTB than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
📊

High ownership — 78% of 3.0Y peak

78% of all-time peak
70 funds currently hold this stock — 78% of the 3.0-year high of 90 funds (reached 2024 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📶

Steady growth — +19% more funds vs a year ago

fund count last 6Q
+11 new funds entered over the past year (+19% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟢

More buyers than sellers — 66% buying

44 buying23 selling
Last quarter: 44 funds were net buyers (28 opened a brand new position + 16 added to an existing one). Only 23 were sellers (13 trimmed + 10 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+15 vs last Q)

new funds entering per quarter
Funds opening a new QTTB position: 8 → 7 → 13 → 28. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔄

Mostly new holders — 49% entered in last year

■ 24% conviction (2yr+) ■ 27% medium ■ 49% new
Only 17 funds (24%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💰

Value +377% but shares only +138% — price-driven

Value
+377%
Shares
+138%
Last quarter: the total dollar value of institutional holdings rose +377%, but actual share count only changed +138%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

11 → 8 → 7 → 13 → 28 new funds/Q
New funds entering each quarter: 8 → 7 → 13 → 28. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
📊

Mixed cohorts — 25% veterans, 42% new entrants

■ 25% veterans ■ 33% 1-2yr ■ 42% new
Of 72 current holders: 18 (25%) held 2+ years, 24 held 1–2 years, 30 (42%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
📋

Smaller funds dominant — 4% AUM from top-100

4% from top-100 AUM funds
17 of 70 holders rank in the top 100 by AUM, but together hold only 4% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
3.4
out of 10
Low Exit Risk
Exit risk score 3.4/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — QTTB

In 2026 Q2, 44 hedge funds were net buyers of QTTB (28 opened a new position, 16 added to an existing one), while 23 reduced or exited (13 trimmed, 10 sold completely) — a 66% buyer ratio, indicating clear institutional accumulation. Net buying has persisted for two consecutive quarters, a positive momentum signal. Net fund flow last quarter: +18 funds (more new holders than closures). Total institutional holders: 70.

Hedge Fund Ownership: QTTB

How many hedge funds hold QTTB — quarterly history vs. share price
Quarterly hedge fund ownership of QTTB vs. share price

Market Analysis: QTTB

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: QTTB

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Q32 Bio Inc (QTTB) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much QTTB has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 81d ago
QTTB
-14.8%
XLV
+6.1%

QTTB outperformed XLV by -20.9% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 36d ago
QTTB
-28.3%
XLV
+0.6%

Since the filing became public, QTTB outperformed XLV by -28.9% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

5 top-rated funds 2 high-conviction
Consensus
3.4
/ 10
breadth
×
Elite
2.5
/ 10
conviction
Hedge Fund Positioning: QTTB
70 + Investors

Track Smart Money conviction in QTTB. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 70 52 34.62%
13F Shares 22M 9M 138.08%
Total Value $283M $59M 376.98%
New Positions 28 13 +15
Increased Positions 16 13 +3
Closed Positions 10 11 -1
Reduced Positions 13 9 +4
Total Calls 0 0 -
Total Puts 2 0 100%
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: QTTB

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

70 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in QTTB. Verified SEC 13F-HR filings.

QUARTER:
Top 25 QTTB holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Atlas Venture Life Science Advisors, LLC 3.93% 2,717,106 $34.6M
2 Boxer Capital Management, LLC 3.02% 3,149,310 $40.1M
3 Opaleye Management Inc. 1.07% 931,000 $11.9M
4 Orbimed Advisors LLC 0.97% 4,127,987 $52.6M
5 Bvf Inc/Il 0.77% 2,350,000 $29.9M
6 Acorn Capital Advisors, LLC 0.75% 216,171 $2.8M
7 Ikarian Capital, LLC 0.59% 430,000 $5.5M
8 Sanofi 0.58% 244,083 $3.1M
9 Logos Global Management LP 0.44% 800,000 $10.2M
10 Monimus Capital Management, LP 0.39% 132,036 $1.7M
11 Ikarian Capital, LLC 0.27% 200,000 $2.5M
12 Ra Capital Management, L.P. 0.26% 2,332,457 $29.7M
13 SummitTX Capital, L.P. 0.24% 733,774 $9.3M
14 Knott David M Jr 0.20% 30,412 $387K
15 DAFNA Capital Management LLC 0.08% 32,896 $419K
16 Boothbay Fund Management, LLC 0.02% 130,427 $1.7M
17 Mangrove Partners IM, LLC 0.02% 22,150 $282K
18 Point72 Asset Management, L.P. 0.02% 1,173,396 $14.9M
19 Affinity Asset Advisors, LLC 0.02% 27,777 $354K
20 Woodline Partners LP 0.01% 286,212 $3.6M
21 Boothbay Fund Management, LLC 0.01% 61,300 $781K
22 Bridgeway Capital Management, LLC 0.01% 34,613 $441K
23 Carlyle Group Inc. 0.01% 60,363 $769K
24 Quadrature Capital Ltd 0.00% 36,396 $464K
25 Renaissance Technologies LLC 0.00% 179,600 $2.3M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Q32 Bio Inc (QTTB)

What does the Smart Money Trend signal show for QTTB?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added QTTB than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for QTTB?

More buyers than sellers — 66% buying: Last quarter: 44 funds were net buyers (28 opened a brand new position + 16 added to an existing one). Only 23 were sellers (13 trimmed + 10 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for QTTB holders?

Smaller funds dominant — 4% AUM from top-100: 17 of 70 holders rank in the top 100 by AUM, but together hold only 4% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held QTTB?

Mostly new holders — 49% entered in last year: Only 17 funds (24%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Q32 Bio Inc (QTTB) following the 2026 Q2 hedge fund 13F filings?

As of today, QTTB has moved -28.3% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.6% for the XLV sector ETF — an outperformance of -28.9%. Since the quarter end (June 30, 2026), QTTB has gained -14.8% vs +6.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →